Abstract
To mitigate the hindered transport of multifunctional diagnostics and therapeutics nanoagents in the tumour tissue, we introduce a new drug delivery concept, which relies on drug container passive accumulation in the tumour vasculature followed by a rapid release of small-molecule payload that penetrates through capillary walls to the tumour interstitium and results in deep penetration in the tumour.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
